27. In human females there is inactivation of one X chromosomes for dosage compensation due to-
(1) Methylation           (2) Acetylation
(3) Phosphorylation    (4) Formylation

In human females, X chromosome inactivation (XCI) for dosage compensation is primarily due to DNA methylation, an epigenetic modification that silences one of the two X chromosomes to balance gene expression between XX females and XY males.

Detailed Explanation

• X chromosome inactivation is an epigenetic process where one X chromosome in females is transcriptionally silenced.

• This silencing is initiated and maintained by the expression of the long non-coding RNA called XIST, which coats the future inactive X chromosome.

• Following XIST coating, various epigenetic modifications occur, including DNA methylation of CpG islands on the inactive X, histone modifications (like deacetylation and methylation), and recruitment of heterochromatin proteins.

• DNA methylation acts as a stable repression mark, preventing transcription machinery from accessing the genes, thereby maintaining the inactive state.

• Other options like acetylation (which usually promotes gene activation), phosphorylation, or formylation do not cause stable gene silencing on the X chromosome in this context.

Explanation of Options

• (1) Methylation: Correct. DNA methylation of the inactive X chromosome is a major mechanism maintaining X chromosome inactivation.

• (2) Acetylation: Incorrect. Histone acetylation generally correlates with gene activation, not inactivation.

• (3) Phosphorylation: Incorrect. Phosphorylation is not a primary mechanism of X chromosome inactivation.

• (4) Formylation: Incorrect. Formylation is not known to play a role in X chromosome inactivation.

Introduction:

In human females, balancing gene dosage between two X chromosomes and one X chromosome in males is achieved by X chromosome inactivation (XCI). This epigenetic process silences one X chromosome, ensuring equal gene expression. DNA methylation, alongside other epigenetic modifications, plays a crucial role in maintaining the inactive state of the X chromosome.

Detailed Explanation:

• XCI begins with expression of XIST RNA, coating the future inactive X chromosome.

• DNA methylation of promoter regions on the inactive X ensures stable long-term gene silencing.

• Other epigenetic changes such as histone modifications support the heterochromatic, transcriptionally inactive state.

• Methylation prevents transcription factor binding and RNA polymerase access, effectively silencing genes on the inactive X.

• This mechanism ensures dosage compensation between sexes and prevents overexpression of X-linked genes.

Option Review:

The correct mechanism for dosage compensation in females is DNA methylation (option 1). Other epigenetic marks like acetylation generally activate gene expression and are not responsible for silencing the X chromosome.

This explanation integrates recent molecular biology insights on X chromosome inactivation and epigenetic regulation, essential for students, educators, and researchers exploring dosage compensation and epigenetics in humans.

This concludes the detailed answer to your question about the mechanism behind X chromosome inactivation in human females.